AGÕæÈ˹ٷ½

STOCK TITAN

DOCGO INC SEC Filings

DCGO NASDAQ

Welcome to our dedicated page for DOCGO SEC filings (Ticker: DCGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Parsing DocGo’s multi-segment disclosures can feel like treating a patient without a chart. The company’s mobile health contracts, ambulance fleet costs, and virtual-care metrics often sit side-by-side in a single document. Whether you’re hunting for how a new city contract shows up in an 8-K or comparing Mobile Health margins across quarters, the details are deep. That’s why investors search for "DocGo SEC filings explained simply"—and why Stock Titan starts by translating the technical language.

Our AI reads every 10-K, 10-Q, 8-K, and Form 4 the moment it hits EDGAR. Within seconds you’ll see

  • AI-powered summaries that surface segment revenue, payer mix, and fleet expansion costs
  • AGÕæÈ˹ٷ½-time alerts on "DocGo Form 4 insider transactions real-time" for fast trade monitoring
  • Expert notes that turn complex healthcare reimbursement tables into plain English
Need a quick dive into the "DocGo quarterly earnings report 10-Q filing" or a deeper "DocGo earnings report filing analysis"? It’s all organized by form type so you can move from headline numbers to footnote details without scrolling through 200 pages.

Investors routinely ask about "DocGo insider trading Form 4 transactions" and "DocGo proxy statement executive compensation" to gauge management’s incentives. Others want the "DocGo annual report 10-K simplified" or "DocGo 8-K material events explained" to understand how new municipal deployments could shift revenue. By "understanding DocGo SEC documents with AI," you’ll pinpoint which units drive growth, track "DocGo executive stock transactions Form 4," and monitor cash burn tied to ambulance acquisitions—information that can influence valuation well before the next earnings call.

Rhea-AI Summary

Bank of Montreal (BMO) is issuing US$90,000 of Senior Medium-Term Notes, Series K—“Digital Return Barrier Notes� due July 3, 2030. The notes are unsecured, unsubordinated obligations linked to the least-performing of three U.S. equity benchmarks: the NASDAQ-100 Index (NDX), the Russell 2000 Index (RTY) and the Dow Jones Industrial Average (INDU).

Key economic terms

  • Digital Return: 61.00% of principal.
  • Digital Barrier Level: 100% of each index’s initial level (no decline permitted for the digital payout).
  • Barrier Level: 70% of initial level. If the least-performing index closes below this level on the valuation date, principal is lost 1-for-1 with the index decline (up to âˆ�100%).
  • Upside Participation: If the least-performing index gains more than 61%, holders receive full participation in that appreciation.
  • Tenor: 5-year term, priced June 30 2025, settles July 3 2025, matures July 3 2030.
  • Denomination: $1,000; CUSIP 06376EGB2.
  • Issue price: 100% of face; agent’s commission 0.50%.
  • Estimated initial value: $962.30 per $1,000 note (reflecting structuring and hedging costs).

Risk highlights

  • No periodic interest and no principal protection below a 30% index decline.
  • Performance tied solely to the worst-performing index; positive moves in the other two indices do not help if one underperforms.
  • Credit risk: payments depend on BMO’s ability to pay; the notes are not FDIC or CDIC insured.
  • Limited liquidity: the notes are not exchange-listed; any secondary trading is at the agent’s discretion and likely at a discount.
  • Tax treatment uncertain; issuer assumes prepaid derivative contract characterization.

Illustrative payouts from the issuer’s table:

  • Index up 10% â†� investor receives $1,610 (61% fixed return).
  • Index unchanged â†� investor still receives $1,610 (61%).
  • Index down 20% (above 70% barrier) â†� investor receives principal ($1,000).
  • Index down 40% â†� investor receives $600 (40% loss).

Because the face amount is de minimis relative to BMO’s balance sheet and no new financial information about the bank is provided, the filing is not considered material to BMO equity investors. It is, however, essential for prospective purchasers of the specific structured note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

JPMorgan Chase Financial Company LLC is offering Leveraged Market-Linked Step Up Notes maturing in July 2027 that are linked to a six-index international equity basket. The basket is weighted 40% EURO STOXX 50, 20% FTSE 100, 20% Nikkei 225, 7.5% Swiss Market Index, 7.5% S&P/ASX 200 and 5% FTSE China 50, making European performance—particularly the EURO STOXX 50—the largest driver of returns.

Return profile at maturity

  • If the basket is flat or higher, holders receive the greater of: (a) principal plus a Step Up Payment of 16â€�18% ($1.60â€�$1.80 per $10 unit) or (b) principal plus 150% of the positive basket return.
  • If the basket declines, investors incur a 1-for-1 loss of principal—up to total loss—based solely on the final basket level.
No interim coupons are paid.

Key structural terms

  • Denomination: $10 per unit; minimum initial order of 10,000 units.
  • Tenor: approximately 2 years.
  • Issuer credit: unsecured note of JPMorgan Chase Financial Company LLC; fully and unconditionally guaranteed by JPMorgan Chase & Co.
  • Fees: $0.20 per unit (sales commission $0.15; structuring fee $0.05).
  • Initial estimated value: $9.50â€�$9.715, below the $10 public offering price due to embedded fees and internal funding assumptions.
  • Secondary market: none expected; JPMS may offer limited, uncommitted liquidity.

Risk highlights

  • Full downside market exposure with no principal protection.
  • Performance measured only on the Final Calculation Day; interim gains can be lost.
  • Credit risk of both issuer and guarantor; notes are not FDIC-insured.
  • Potential conflict of interest as JPMS is calculation agent and hedging counterparty.
  • Estimated value discount and fees create negative carry for investors exiting early.

The product suits investors with a bullish or neutral two-year view on the basket who can tolerate full loss of principal, forgo dividends and accept limited liquidity in exchange for enhanced upside participation and a defined minimum positive return.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

GS Finance Corp. is offering $1.08 million of Autocallable Contingent Coupon Equity-Linked Notes due 2028, fully and unconditionally guaranteed by The Goldman Sachs Group, Inc. The notes are tied to the performance of Palantir Technologies Inc. (PLTR) Class A common shares and form part of Goldman’s Series F medium-term note program.

Key commercial terms

  • Face amount: $1,000 per note (aggregate $1.08 million)
  • Issue price: 100% (trade date 30-Jun-2025; settlement 03-Jul-2025)
  • Quarterly contingent coupon: $69.625 (6.9625% per quarter, up to 27.85% p.a.) payable only if PLTR closes at or above 60% of the initial price ($136.32) on the relevant observation date.
  • Automatic call: If PLTR closes at or above the initial price on any quarterly call observation date from Sep-2025 to Mar-2028, the notes are redeemed at par plus the due coupon.
  • Downside protection: 40% buffer. If the final price on 30-Jun-2028 is â‰�60% of the initial price, holders receive par plus any final coupon. If below 60%, repayment equals par plus (index return × par), exposing investors to full downside beyond the buffer.
  • Estimated value at pricing: ~$970 per $1,000, reflecting structuring fees and dealer margin; underwriting discount 2%.
  • Secondary market: GS & Co. may, but is not obliged to, make a market; bid/ask reflects estimated value plus declining premium (initially $25).
  • Credit: senior unsecured obligation of GS Finance Corp. with unconditional guarantee from The Goldman Sachs Group, Inc.; not FDIC insured.

Risk highlights

  • Investors may receive no coupons if PLTR trades below the 60% trigger on observation dates.
  • If PLTR falls >40% at maturity and the note hasn’t been called, principal loss is one-for-one with the stock’s decline.
  • Limited upside: maximum redemption is par plus due coupon; investors do not participate in stock gains above par.
  • Market value likely to be below issue price; liquidity limited; pricing sensitive to GS credit spreads, PLTR volatility and interest rates.
  • Product complexity, dilution events, market disruption adjustments and discretionary determinations by GS & Co. add additional risks.

The prospectus supplement also details anti-dilution adjustments, default provisions, tax characterization (income-bearing prepaid derivative contract) and extensive hypothetical scenarios illustrating coupon and principal outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Form 4 filing: On 06/20/2025 Evolv Technologies Holdings, Inc. (EVLV) reported that Director Kimberly H. Sheehy received 27,050 Restricted Stock Units (RSUs). Each RSU converts into one share of Class A common stock and carries no exercise price.

The RSUs vest in full on the earlier of 06/20/2026 or the day immediately preceding the company’s next annual meeting, promoting near-term board alignment. No shares were sold or disposed of, and the entire award is held directly by the reporting person. After the grant, Sheehy beneficially owns 27,050 derivative securities tied to EVLV shares.

This appears to be a routine director compensation grant. While it slightly increases potential share count, the dilution effect is minimal. Nonetheless, the award strengthens the director’s economic stake, which investors may view as a modestly positive governance signal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
current report

FAQ

What is the current stock price of DOCGO (DCGO)?

The current stock price of DOCGO (DCGO) is $1.33 as of August 1, 2025.

What is the market cap of DOCGO (DCGO)?

The market cap of DOCGO (DCGO) is approximately 140.7M.

What is DocGo Inc's primary business focus?

DocGo Inc focuses on mobile health services and integrated medical mobility solutions, delivering healthcare directly to patients at various locations.

How does DocGo Inc generate revenue?

The company generates revenue primarily through its Mobile Health Services segment, complemented by its Transportation Services and Corporate segments, offering diverse healthcare and mobility solutions.

In which markets does DocGo Inc operate?

DocGo Inc operates across 26 US states and the United Kingdom, serving a wide range of settings from residential areas to large-scale events.

What distinguishes DocGo Inc in the healthcare industry?

DocGo Inc's unique integration of on-site healthcare, virtual care management, and specialized transport services distinguishes its operational model in the healthcare and mobility sectors.

How does DocGo Inc integrate technology into its services?

The company utilizes an advanced care delivery platform that streamlines mobile, virtual, and transport logistics, enhancing service efficiency and ensuring timely medical care.

How does DocGo Inc compare with traditional ambulance services?

Unlike traditional ambulance services, DocGo Inc offers a hybrid model combining on-site, mobile, and virtual care, providing comprehensive and adaptable healthcare solutions.

What value does DocGo Inc provide to its clients?

DocGo Inc offers value by ensuring accessible and adaptable healthcare through innovative medical mobility solutions, catering to diverse client needs in various environments.
DOCGO INC

NASDAQ:DCGO

DCGO Rankings

DCGO Stock Data

140.73M
92.05M
8.83%
52.43%
7.56%
Medical Care Facilities
Services-health Services
United States
NEW YORK